ABSCTRACT Introduction: Prostate neoplasia is the second most diagnosed cancer in men, having well established risk factors such as advanced age, familial and ethnic susceptibility. Recently, the association with environmental or lifestyle factors has been investigated, opening the possibility of certain occupational risk factors being associated with a higher incidence of this disease. Although controversial, as it does not necessarily imply a malignant etiology, prostate-specific antigen remains the mainstay in screening for this disease. Case report: This is the case of a 60-year-old surgeon with 36 years of professional history, including shift and night-work. As part of the health surveillance carried out by Occupational Medicine, he underwent complementary diagnostic tests and an increase in prostate-specific antigen was detected, culminating in a biopsy which ultimately confirmed the diagnosis of prostate adenocarcinoma. Discussion/Conclusion: Shift work, and particularly night work, has been investigated as a possible carcinogen and is currently classified by the International Agency for Research on Cancer as "probably carcinogenic to humans". Given the growing evidence linking certain occupational factors with this and other neoplasms, it may be sensible to include cancer screening in workers' health surveillance protocols, in some sectors. In the case presented, the inclusion of prostate-specific antigen measurement in the complementary tests requested by Occupational Medicine allowed for a timely diagnosis, with detection and treatment of the disease at an early stage.

RESUMO Introdução: A neoplasia da próstata é a segunda mais comummente diagnosticada no sexo masculino, destacando-se como fatores de risco bem estabelecidos a idade avançada, a suscetibilidade familiar e étnica. Recentemente, a associação a fatores ambientais ou de estilo de vida tem vindo a ser investigada, abrindo a possibilidade à associação de fatores de risco ocupacionais com uma maior incidência desta patologia. Apesar de controverso por não significar necessariamente a existência de patologia maligna, o antigénio específico da próstata mantém-se como o pilar no rastreio desta doença. Descrição do caso: Trata-se do caso de um cirurgião de 60 anos, com 36 anos desta atividade profissional, realizando trabalho por turnos e trabalho noturno. No âmbito da vigilância da saúde realizada pela Saúde Ocupacional, é submetido a exames complementares de diagnóstico, detetando-se um aumento do antigénio específico da próstata, que culmina na realização de biópsia, confirmando o diagnóstico de adenocarcinoma da próstata. Discussão/Conclusão: O trabalho por turnos e, particularmente, o trabalho noturno, tem vindo a ser investigado como possivelmente carcinogénico, estando, atualmente, classificado pela Agência Internacional para a Investigação em Cancro como “provavelmente carcinogénico para humanos”. Tendo em conta a crescente evidência relacionando fatores ocupacionais com esta e outras neoplasias, poderá fazer sentido incluir rastreios oncológicos nos protocolos de vigilância da saúde dos trabalhadores, em alguns setores. No caso apresentado, a inclusão da medição de antigénio específico da próstata nos exames complementares pedidos pela Saúde Ocupacional permitiu um diagnóstico atempado, com deteção e tratamento da doença numa fase precoce.

ABSTRACT Introduction: Every year more than 2.3 million cases of breast cancer are registered, making it the most common type of cancer among adults. The association between breast cancer and occupational factors is an issue that has been studied in the literature since the beginning of the 18th century. Technological developments have allowed a more in-depth study of the relationship between breast cancer and occupational factors such as exposure to chemicals, pesticides, metals and also sources of exposure to ionising and non-ionising radiation.The aim of the present literature review is to complete an update on the scientific knowledge about the relationship between occupational exposure to ionising radiation in healthcare workers and the development of breast cancer. Methodology: A research was carried using Medline with the PubMed search engine and Elsevier with the Science Direct search engine. The search words used were a combination of breast cancer, occupational exposure, ionizing radiation and healthcare workers. A research was also carried out in Revista Portuguesa de Saúde Ocupacional, using the terms “Breast Cancer” and “Ionizing Radiation”. Discussion/Conclusions: Current literature is not unanimous about the specific clinical and pathological features of breast cancer possibly linked to occupational settings. Healthcare professionals such as radiology technicians, nurses, orthopaedic surgeons and interventional cardiologists are especially vulnerable to this type of exposure, particularly to ionising radiation. However, some studies have pointed to a difficulty in establishing a causal relationship between these factors due to the number of variables involved, such as the duration and intensity of exposure and the influence of other risk factors. Changes in equipment, procedures and protective measures have resulted in lower doses in recent years, which means that the risk of breast cancer is low at current levels of occupational exposure to ionizing radiation.

RESUMO Introdução: Todos os anos são registados mais de 2,3 milhões de casos de cancro da mama, o que o torna o tipo cancro mais comum entre os adultos. A associação entre o cancro da mama e fatores ocupacionais é uma questão que tem vindo a ser estudada na literatura desde o início do século XVIII. Os desenvolvimentos tecnológicos permitiram um estudo mais aprofundado sobre a relação entre o cancro da mama e os fatores profissionais como a exposição a produtos químicos, pesticidas, metais e também fontes de exposição a radiação ionizante e não ionizante. O objetivo da presente revisão de literatura é incidir na relação entre a exposição ocupacional a radiação ionizante em trabalhadores da saúde e o desenvolvimento de cancro da mama. Metodologia: Foi efetuada uma pesquisa na Medline, com o motor de busca PubMed e na Elsevier, com o motor de busca Science Direct. As palavras de pesquisa usadas foram uma combinação dos termos breast cancer, occupational exposure, ionizing radiation e healthcare workers. Foi também realizada pesquisa na Revista Portuguesa de Saúde Ocupacional utilizando os termos “Cancro de mama” e “Radiação Ionizante”. Discussão/Conclusão: A literatura atual não é unânime quanto às características clínicas e patológicas específicas do cancro da mama possivelmente ligadas a contextos profissionais. Os profissionais de saúde, tais como técnicos de radiologia, enfermeiros, cirurgiões ortopédicos e cardiologistas de intervenção são especialmente vulneráveis a este tipo de exposição, nomeadamente à radiação ionizante. No entanto, alguns estudos apontaram para uma dificuldade em estabelecer uma relação causal entre estes fatores e o desenvolvimento de doença devido ao número de variáveis envolvidas, tais como a duração e intensidade da exposição e à influência de outros fatores de risco. As mudanças no equipamento, procedimentos e medidas de proteção resultaram em doses mais baixas nos anos mais recentes, o que significa que o risco de cancro da mama é baixo nos níveis atuais de exposição profissional à radiação ionizante.

Resumen El presente trabajo tiene como propósito explicar la distribución y comportamiento de la mortalidad de cáncer de próstata en Costa Rica, a partir del acceso geográfico a los servicios de salud por cantón. Metodológicamente, se presenta un análisis de tipo ecológico, cuya fuente de información es la base de datos de defunciones del Instituto Nacional de Estadísticas y Censo. Para estudiar la asociación entre la mortalidad y el acceso a los servicios de salud, se diseñó el Índice de Acceso Geográfico a los Servicios de Salud (IAGSS), y se aplicaron modelos de regresión de Poisson a la Geographically Weighted Regression (GWR). Como principales resultados, se encontró una tendencia creciente de la enfermedad en la población. El IAGSS, muestra que el acceso a los servicios de salud no se distribuye de manera uniforme en el territorio, y se asocia con la mortalidad por CaP. Se concluye que la zona norte del país presenta la mayor desventaja en el acceso a servicios de salud, y que los territorios con peor IAGSS tienden a incrementar la mortalidad por CaP.

Resumo O objetivo deste trabalho é elucidar a distribuição e o comportamento da mortalidade por câncer de próstata (CaP) na Costa Rica, com base no acesso geográfico aos serviços de saúde por município. Metodologicamente, é apresentada uma análise de tipo ecológico, cuja fonte de informação é a base de dados de óbitos do Instituto Nacional de Estatísticas e Censo. Para estudar a associação entre a mortalidade e o acesso aos serviços de saúde, foi elaborado o Índice de Acesso Geográfico aos Serviços de Saúde (IAGSS) e foram utilizados modelos de regressão de Poisson à Geographically Weighted Regression (GWR). Como principais resultados, foi identificada uma tendência crescente da doença na população. O IAGSS mostra que o acesso aos serviços de saúde não é distribuído de forma uniforme no território e está associado à mortalidade por CaP. Conclui-se que a região norte do país apresenta a maior desvantagem no acesso aos serviços de saúde, e que os territórios com pior IAGSS tendem a aumentar a mortalidade por CaP.

Abstract This paper aims to explain the distribution and behavior of prostate cancer mortality in Costa Rica based on geographic access to health services by municipalities. Methodologically, an ecological analysis is presented; its information source is the death database of the National Institute of Statistics and Census. To study the association between mortality and access to health services, the authors designed the Geographic Access Index to Health Services (GAIHS) and implemented Poisson regression models and the Geographically Weighted Regression (GWR). As a main result, an increasing trend of the disease in the population was found. The GAIHS shows that access to health services is not evenly distributed in the territory and is associated with PCa mortality. It is concluded that the northern zone of the country presents the greatest disadvantage in access to health services and that the territories with the worst GAIHS tend to increase mortality from PCa.

Breast cancer is the most commonly diagnosed cancer and the second most common cause of cancer death in women. The anthracycline, doxorubicin, is a well-known and highly effective treatment for breast cancer patients; however, many patients present with resistance to chemotherapeutic drugs, which ultimately results in treatment failure and contributes to high mortality rates. It is well established that the mitogen-activated protein kinase phosphatase 1 (MKP-1) mediates the response to chemotherapy, where upregulated MKP-1 is associated with chemoresistance. We investigated whether MKP-1 inhibition or silencing can sensitise triple-negative MDA-MB-231 breast cancer cells to doxorubicin therapy. We found that MKP-1 inhibition and silencing sensitises breast cancer cells to doxorubicin-induced apoptosis. Additionally, the inhibition of MKP-1 in combination with doxorubicin treatment promotes autophagy induction, while doxorubicin and not MKP-1 modulation increased lysosomal acidic compartments. As such, this study demonstrated that MKP-1 inhibition has a potential therapeutic benefit for breast cancer patients by increasing the efficacy of conventional chemotherapy. Therefore, MKP-1 inhibition should be developed as a clinically relevant adjuvant therapy, which could provide a novel avenue for therapeutic intervention in combination with chemotherapy in breast cancer patients. SIGNIFICANCE: • MKP-1 inhibition with sanguinarine and silencing sensitises breast cancer cells to doxorubicin-induced apoptosis. • The inhibition of MKP-1 with sanguinarine in combination with doxorubicin treatment promotes autophagy induction. • MKP-1 inhibition can have a potential therapeutic benefit for breast cancer patients by increasing the efficacy of conventional chemotherapy.

ABSTRACT The Center of Molecular Immunology is an exponent of Cuban biotechnology institution dedicated to basic research, development, production and commercialization of biopharmaceuticals, with the aim of diagnosing and treating cancer and diseases related to the immune system. In this work, a bibliographic synthesis of research that was carried out in this center in the period from 2012 to 2018, was performed, with the purpose of analyzing the application of some Data Mining techniques in the evaluation of fermentation and purification stages of the process for obtaining biopharmaceuticals in three production facilities. The phases of Data Mining were characterized and the practical implication of the results was presented. Principal Components Analysis was applied as a descriptive model using THE UNSCRAMBLER software, and Artificial Neural Networks were applied as a predictive model using the MATLAB neural networks toolbox. The use of these models made it possible to extract useful information for decision making, thereby explaining the behavior of the parameters that influence the quality of the final product, as well as estimating important variables such as the concentration of the protein of interest in the fermentation supernatant and the performance of the purification stage, depending on the process variables that have the greatest influence on its behavior.

RESUMEN El Centro de Inmunología Molecular es una institución exponente de la biotecnología cubana dedicado a la investigación básica, desarrollo, producción y comercialización de biofármacos, con el objetivo de diagnosticar y tratar el cáncer, así como enfermedades relacionadas con el sistema inmune. En este trabajo se realizó una síntesis bibliográfica de investigaciones que se llevaron a cabo en este centro, en el periodo comprendido del 2012 al 2018, con el propósito de analizar la aplicación de algunas técnicas de Minería de Datos en la evaluación de las etapas de fermentación y purificación del proceso de obtención de biofármacos en tres instalaciones productivas. Se caracterizaron las fases de la Minería de Datos y se presentó la implicación práctica de los resultados. Se aplicó como modelo descriptivo el Análisis de Componentes Principales mediante el software THE UNSCRAMBLER, y como modelo predictivo las Redes Neuronales Artificiales con el empleo de la caja de herramientas de redes neuronales del MATLAB. La utilización de estos modelos permitió extraer información útil para la toma de decisiones, se logró con ello explicar el comportamiento de los parámetros que influyen en la calidad del producto final, así como estimar variables de importancia como la concentración de la proteína de interés en el sobrenadante de la fermentación y el rendimiento de la etapa de purificación, en función de las variables del proceso que mayor influencia tienen en su comportamiento.

Abstract Contrast-enhanced digital mammography (CEDM) is an emerging tool that has been increasingly implemented. It appears as an alternative to magnetic resonance imaging (MRI), using intravenous contrast to explore tumor angiogenesis. It combines conventional mammography (Mx) with post-contrast dual energy subtraction technique, resulting in increased detection of breast cancer, in a short study time and at a low cost. It is a promising method in selected cases and easy to read, being useful mainly in patients with breast cancer to detect additional lesions and determine the tumor size, that helps surgical planning, as well as in the evaluation of post-neoadjuvant chemotherapy response in the follow-up of patients treated with surgery, to address inconclusive findings in screening mammogram, or as an alternative when MRI is contraindicated. The purpose of this article is to assess the usefulness of contrasted mammography in daily practice and to determine its main indications. We review with our own cases the applications and characteristics of this method.

Resumen La mamografía contrastada (CEDM, contrast-enhanced digital mammography) es una herramienta nueva que ha ido implementándose de forma creciente. Aparece como alternativa a la resonancia magnética (RM), y al igual que esta, tiene como principio el uso de contraste endovenoso para explorar la angiogénesis tumoral. Combina la imagen de mamografía convencional (Mx) con la técnica de sustracción con energía dual poscontraste, lo que resulta en un incremento en la detección de cáncer de mama, en un tiempo corto de estudio y a un bajo costo. Es un método prometedor en casos seleccionados y de fácil lectura, siendo útil principalmente en pacientes con diagnóstico de cáncer de mama para detectar lesiones adicionales y determinar el tamaño tumoral, ayudando en la planificación quirúrgica, así como también en la evaluación de la respuesta a la neoadyuvancia. También en el seguimiento de pacientes operadas, para caracterizar lesiones dudosas en Mx y ecografía, o como alternativa ante contraindicación de la RM. El objetivo de este trabajo es valorar la utilidad de la mamografía contrastada en la práctica diaria y determinar sus principales indicaciones. Repasamos con casos propios las utilidades y características del método.

ABSTRACT Introduction: cancer entails a mortality of up to 12 % in transplanted patients and is considered the third leading cause of morbidity and mortality in recipients who are susceptible to develop oncoproliferative diseases in the long term. Objective: to describe the incidence of neoplasms in renal transplant recipients. Methods: we carried out a descriptive and longitudinal study including 15 functioning renal transplant recipients who were diagnosed with malignant neoplasms in different locations in the Nephrology service at “Arnaldo Milián Castro” Clinical and Surgical University Hospital in Santa Clara, Villa Clara between January 2017 and June 2023. Results: males and white skin color predominated: 53.3 % and 73.3% respectively, with post-transplant time greater than three years in 12 patients (80 %). The history of cytomegalovirus exposure represented 80 %; bacterial infection of the respiratory and digestive tracts was the most frequent. Conclusions: cervicouterine intraepithelial neoplasia, colon cancer with liver and brain metastases were the most frequent and treated with surgery chemotherapies or both according to the surgical criteria in each case; however, mortality was elevated. Cervical intraepithelial neoplasia predominated in a 26.6 %. Mortality was high and survival was lower in males, without exceeding two years after the diagnosis.

RESUMEN Introducción: El cáncer conlleva a una mortalidad de hasta 12 % en los pacientes trasplantados, y se considera la tercera causa de morbilidad y mortalidad en los receptores, al ser estos susceptibles a desarrollar enfermedades oncoproliferativas, a largo plazo. Objetivo: Describir la incidencia de neoplasias en receptores de trasplante renal. Métodos: Estudio descriptivo y longitudinal que incluyó 15 receptores de trasplante renal funcionante, con diagnóstico de neoplasias malignas en diferentes localizaciones en el período comprendido entre enero de 2017 y junio de 2023 en el servicio de Nefrología del Hospital Universitario Clínico-Quirúrgico «Arnaldo Milián Castro» de Santa Clara, Villa Clara. Resultados: Predominaron los hombres y el color de piel blanca: 53,3 % y 73,3% respectivamente, con tiempo postrasplante superior a tres años en 12 pacientes (80 %). El antecedente de exposición al citomegalovirus representó el 80 %; la infección bacteriana de la vía respiratoria y digestiva fue la más frecuente. Conclusiones: La neoplasia intraepitelial cervicouterina, la de colon con metástasis hepática y las cerebrales resultaron las más frecuentes, y fueron tratadas con cirugía, quimioterapias o ambas, según los criterios quirúrgicos en cada caso; no obstante, la mortalidad fue elevada. La estirpe neoplásica preponderante fue la neoplasia intraepitelial cervical en un 26,6 %. La mortalidad fue alta y la supervivencia fue menor en el sexo masculino, sin rebasar los dos años posteriores al diagnóstico.

ABSTRACT Introduction: bladder cancer is one of the most frequent cancers of the urinary tract and manifests itself in two ways: as a superficial low-grade tumor or as a high-grade invasive neoplasm. Objective: to characterize bladder cancer in adults according to clinical, epidemiological and service variables. Methods: a descriptive and retrospective observational study was carried out to characterize bladder cancer in adults according to clinical, epidemiological and service variables of patients treated in the Urology service at "Arnaldo Milián Castro" Clinical and Surgical University Hospital from October 2019 and 2022. The study population was 242 patients diagnosed with bladder cancer. Results: most of the patients diagnosed with bladder cancer correspond to the year 2019 (45.86%): male (75.20%); whites (89.25%); older than 70 or more years (64.46%) and smokers (95.45%). Hematuria was the main symptom (91.73%), as an expression of low-grade papillary urothelial carcinoma (36.77%). The treatment was transurethral resection (88.01%), without distant metastasis (88.42%). Conclusions: most of the patients diagnosed with bladder cancer correspond to the year 2019, male, whites, older than 70 years or older, smokers and with hematuria. Low-grade papillary urothelial carcinoma was the most frequent cancer. The time elapsed before the diagnosis of the disease was 36-40 days, and the time elapsed before the treatment of the disease was 1 month.

RESUMEN Introducción: El cáncer de la vejiga es uno de los más frecuentes del tracto urinario y se manifiesta de dos formas: como tumor superficial de bajo grado o como neoplasia invasora de alto grado. Objetivo: Caracterizar el cáncer vesical en adultos, según variables clínicas, epidemiológicas y de servicio. Métodos: Se realizó un estudio observacional descriptivo y retrospectivo, para caracterizar el cáncer vesical en adultos, según variables clínicas, epidemiológicas y de servicio de los pacientes atendidos en el servicio de Urología del Hospital Universitario Clínico-Quirúrgico «Arnaldo Milián Castro» en el periodo comprendido de octubre 2019 y 2022. Población del estudio: 242 pacientes diagnosticados con cáncer vesical. Resultados: La mayoría de los pacientes diagnosticados con cáncer vesical corresponden al año 2019 (45,86 %): masculinos (75,20 %); blancos (89,25 %); mayores de 70 o más años (64,46 %) y fumadores (95,45 %). La hematuria fue el síntoma principal (91,73 %), como expresión del carcinoma urotelial papilar de bajo grado (36,77 %). Tratamiento: la resección transuretral (88,01 %), sin metástasis a distancia (88,42 %). Conclusiones: La mayoría de los pacientes diagnosticados con cáncer vesical corresponden al año 2019, masculinos, blancos, mayores de 70 o más años, fumadores y con hematuria. Más frecuente: el carcinoma urotelial papilar de bajo grado. El tiempo trascurrido antes del diagnóstico de la enfermedad fue de 36-40 días, y un mes, el tiempo trascurrido antes del tratamiento de la enfermedad.

ABSTRACT Introduction: lung cancer became the second cause of death in 2020 according to data from the World Health Organization. Primary lung cancer is very common although the lungs are also a frequent site of metastasis originated from extrathoracic organs. Objective: to characterize patients with lung cancer according to clinical and epidemiological variables. Methods: an observational, descriptive and retrospective study was carried out to characterize clinically and epidemiologically the presence of lung cancer in 110 adult patients treated in the Pulmonology service at “Arnaldo Milıán Castro” Clinical and Surgical University Hospital from October 2020 to October 2022. Results: most of the patients diagnosed with lung cancer corresponded to the year 2020 (38.18%): female (59.09%), white (59.09%), age group 60 - 69 years (44.50 %), retirees (63.63%), smokers (82.72%) and with a family history of this disease (97.27%). Cough was the main symptom (95.45%) and infiltrating poorly differentiated squamous cell carcinoma predominated (19.09%). The type of lung cancer was non-small cell cancer (84.54%) and the treatment was chemotherapy (49.09%). Conclusions: patients with lung cancer were diagnosed more frequently in 2020. Subjects over 60 years old, female gender, white skin color, retirees and smokers predominated. The most common histological variety was non-small- cell lung cancer and infiltrating poorly differentiated squamous cell carcinoma predominated.

RESUMEN Introducción: En 2020, el cáncer de pulmón se convirtió en la segunda causa de muerte, según datos de la Organización Mundial de la Salud. Aunque los pulmones son un asiento frecuente de metástasis de cánceres originados en órganos extratorácicos, el cáncer primario pulmonar también es muy frecuente. Objetivo: Caracterizar a los pacientes con cáncer pulmonar según variables clínicas y epidemiológicas. Métodos: Se realizó un estudio observacional descriptivo y retrospectivo para caracterizar la presencia de cáncer pulmonar de acuerdo con dos variables (clínicas y epidemiológicas), en 110 pacientes adultos atendidos en el servicio de Neumología del Hospital Universitario Clínico-Quirúrgico «Arnaldo Milián Castro», en el período comprendido de octubre 2020 a octubre 2022. Resultados: La mayoría de los pacientes diagnosticados con cáncer pulmonar correspondieron al año 2020 (38,18 %): femeninos (59,09 %), blancos (59,09 %), grupo de edad de 60 - 69 años (44,50 %), jubilados (63,63 %), fumadores (82,72 %), y con antecedentes familiares de esta enfermedad (97,27 %). La tos fue el síntoma principal (95,45 %) y predominó el carcinoma escamoso poco diferenciado infiltrante (19,09 %). El tipo de cáncer pulmonar fue el de células no pequeñas(84,54 %) y como tratamiento, la quimioterapia (49,09 %). Conclusiones: Los pacientes con cáncer de pulmón fueron diagnosticados con más frecuencia en 2020, predominó el sexo femenino y el color de la piel blanco, mayores de 60 años, jubilados y fumadores. La variedad histológica más frecuente fue el carcinoma de células no pequeñas, y de ellos, el escamoso poco diferenciado infiltrante.

Abstract Background: Magnetic Resonance Imaging (MRI) of the prostate is a key diagnostic tool for identifying prostate carcinoma. The Prostate Imaging-Reporting and Data System (PI-RADS) scale is the standard system for interpreting these images. Standardizing and evaluating this scale is crucial for ensuring consistent and reproducible results. Objective: This study aims to assess both the interobserver and intraobserver agreement of the PI-RADS version 2.1. Material and methods: In this retrospective observational study, 129 prostate MRI scans from patients with suspected prostate cancer were evaluated. Three radiologists, each with different levels of experience, analyzed these scans at two separate times using the PI-RADS 2.1 scoring system. Both intraobserver and interobserver agreements were measured. Results: The study found substantial interobserver agreement (kappa > 0.6) across all categories, with category 5 showing the highest level of agreement. Intraobserver reproducibility was also high, with the highest kappa value reaching 0.856. Further analysis based on the radiologists’ years of experience revealed significant interobserver agreement in all instances. Conclusions: The PI-RADS 2.1 classification system demonstrates high reproducibility across different categories, particularly for lesions more likely to be clinically significant cancers. This underscores its reliability in varied diagnostic scenarios.

Resumen Antecedentes: La resonancia magnética (RM) de próstata es uno de los métodos diagnósticos para la identificación del carcinoma de próstata. La escala PI-RADS (Prostate Imaging and Reporting Data System) es el sistema usado para la interpretación de estas imágenes. Es importante, para su reproducibilidad, la estandarización y la evaluación de dicha escala. Objetivo: Determinar la concordancia inter- e intraobservador de la versión 2.1 del PI-RADS. Material y métodos: Estudio observacional retrospectivo, evaluando 129 RM de pacientes con sospecha de cáncer de próstata por tres radiólogos con diferentes años de experiencia y en dos momentos del tiempo, usando el puntaje PI-RADS 2.1. Se evaluó la concordancia intra- e interobservador. Resultados: La concordancia interobservador fue sustancial (kappa > 0,6) en todos los observadores, siendo la categoría 5 la de mayor acuerdo interobservador. Se observó una alta reproducibilidad intraobservardor, con la mayor kappa siendo de 0,856. Cuando se realizó el análisis según años de experiencia de los radiólogos, la concordancia interobservador fue significativa en todos los casos. Conclusiones: El sistema de clasificación PI-RADS 2.1 es reproducible para las diferentes categorías y aumenta la concordancia cuando se trata de lesiones con mayor probabilidad de cáncer clínicamente significativo.

Abstract During the last decades, the magnetic resonance imaging (MRI) has become an strategic tool for diagnosis, staging and surveillance in patients with rectal cancer. To differentiate patients with locally advanced rectal tumors from those who do not, determinate neoadjuvant therapy or total mesorectal excision, respectively. After neoadjuvant chemoradiotherapy, those who achieve complete clinical response may be considered for inclusion in an active surveillance scheme known as “watch and wait” (WW). WW strategy consists of three pillars, rectal digital exam, endoscopy and the MRI, and the main purpose is to reach the early detection of tumoral regrowth. Regarding MRI, the high-resolution T2-weighted images in conjunction with DWI, and the ADC map plays a key role in this instance. WW leads to avoid resective surgeries with high morbidity rates. The rectal digital exam and endoscopy are complementaries to MRI, whose main limitation is the detection of lesions with no mucosal involvement. This reason places the MRI as a cornerstone in tumoral regrowth, detecting not only luminal regrowth, but those in which the rectal wall is not involved, and thus, not accessible for the other surveillance methods. To our knowledge, this is the first pictorial essay in which imaging regrowth patterns are described. The purpose of this is to emphasize the MRI protocol study and to describe the different forms of tumoral regrowth in order to reach the early tumoral regrowth detection.

Resumen En las últimas décadas, la resonancia magnética (RM) ha cobrado un rol fundamental en el diagnóstico, la estadificación y el seguimiento de los pacientes con cáncer de recto. En la estadificación inicial, que sean o no tumores localmente avanzados es lo que determina el tratamiento neoadyuvante o quirúrgico, respectivamente. Posterior a la neoadyuvancia, los pacientes que logren una respuesta clínica completa pueden ser considerados para la inclusión dentro de un esquema de vigilancia activa, comúnmente conocido como watch and wait (WW). La estrategia WW se basa en tres pilares, que son el examen digital rectal, la endoscopía y la RM, buscando detectar la presencia temprana de recrecimiento tumoral. En relación a la RM, la secuencia potenciada en T2 de alta resolución, junto con la de difusión (DWI) y el mapa de ADC, son las piezas clave para la detección temprana de recrecimiento. La estrategia de WW lleva a evitar cirugías resectivas con una alta morbilidad y deterioro de la calidad de vida. El examen digital rectal y la endoscopía son métodos de vigilancia complementarios a la RM, con su principal limitación en lesiones sin compromiso mucoso. Esta razón posiciona a la RM como un pilar indispensable para su implementación, detectando no solo áreas de recrecimiento parietal, sino también aquellas extramurales no accesibles por los otros métodos de vigilancia. En nuestro conocimiento, este es el primer ensayo iconográfico que se centra en el análisis estricto del recrecimiento tumoral en pacientes bajo esquema de WW por RM. El objetivo es enfatizar el protocolo de estudio en estos pacientes y mostrar las distintas formas de recrecimiento tumoral con el fin de lograr su detección temprana.

Resumo: Introdução: O câncer de mama é o tumor maligno mais comum e a principal causa de morte por câncer em mulheres no Uruguai e no mundo. Evidências epidemiológicas sugerem que o câncer de mama se comportaria como patologias distintas em diferentes faixas etárias. O objetivo deste trabalho é caracterizar o câncer de mama no Uruguai para diferentes faixas etárias. Materiais e Métodos: São analisadas as tendências temporais da incidência de câncer de mama em mulheres no Uruguai no período 2002-2019 e a mortalidade por esta causa no período 1990-2020. Para o quinquénio 2015-2019 são também analisadas a distribuição dos estádios ao diagnóstico e os perfis biológicos (Luminal, Triplo negativo e Her2 positivo). São analisados três segmentos etários: mulheres dos 20 aos 44 anos, dos 45 aos 69 anos e dos 70 anos ou mais. Resultados: As taxas de incidência para todas as idades permaneceram estáveis no período 2002-2019 enquanto a mortalidade apresentou tendência decrescente no período 1990-2020. Nas mulheres com menos de 45 anos verifica-se um aumento da incidência, com uma redução da mortalidade até 2010, seguida de uma estabilização das taxas; nas mulheres de 45 a 69 anos, a incidência permanece estável e a mortalidade diminui; nas pessoas com mais de 70 anos, a incidência diminui enquanto a mortalidade permanece estável. Mais de 70% dos casos são diagnosticados nos estágios I e II. Os tumores luminais (receptor hormonal positivo, Her2 negativo) são o subtipo mais comum para todos os grupos sem do que a proporção de tumores com essas características aumenta com a idade, enquanto a proporção de (Her2 positivo e triplo negativo) diminui. Conclusão: Nas mulheres uruguaias, o câncer de mama apresenta características diferenciadas para as três faixas etárias analisadas.

Abstract: Introduction: Breast cancer is the most common malignant tumor and the leading cause of cancer death in women in Uruguay and worldwide. Epidemiological evidence suggests that breast cancer in different age groups behaves as distinct pathologies. The objective of this work is to characterize breast cancer in Uruguay for different age groups. Method: Temporal trends in the incidence of breast cancer in women in Uruguay are analyzed for the period 2002-2019, along with mortality trends for this cause from 1990 to 2020. For the five-year period 2015-2019, the distribution of stages at diagnosis and biological profiles (Luminal, Triple-negative, and Her2 positive) is also analyzed. Three age segments are analyzed: women aged 20 to 44 years, 45 to 69 years, and 70 years and older. Results: The incidence rates for all age groups remained stable during the period 2002-2019, while mortality showed a decreasing trend in the period 1990-2020. In women under 45, there is an increase in incidence, with mortality decreasing until 2010, followed by a stabilization of rates; in women aged 45 to 69, incidence remains stable and mortality decreases; in those over 70, incidence decreases while mortality remains stable. More than 70% of cases are diagnosed at stages I and II. Luminal tumors (hormone receptor positive, Her2 negative) are the most frequent subtype for all age groups. The proportion of tumors with these characteristics increases with age, while the proportion of Her2 positive and triple-negative tumors decreases. Conclusions: In Uruguayan women, breast cancer presents differential characteristics for the three age groups analyzed.

Resumen: Introducción: el cáncer de mama es el tumor maligno más frecuente y la primera causa de muerte por cáncer en mujeres en Uruguay y en el mundo. La evidencia epidemiológica sugiere que el cáncer de mama en diferentes grupos de edades se comportaría como patologías distintas. El objetivo de este trabajo es caracterizar el cáncer de mama en Uruguay para diferentes estratos de edades. Material y método: se analizaron las tendencias temporales de la incidencia de cáncer de mama en mujeres en Uruguay en el período 2002-2019, y de la mortalidad por esta causa en 1990-2020. Para el quinquenio 2015-2019, se analiza además la distribución de estadios al diagnóstico y de perfiles biológicos (luminales, triple negativos y HER2 positivos). Se analizan tres segmentos de edades: mujeres de 20 a 44 años, de 45 a 69 y de 70 y más años. Resultados: las tasas de incidencia para el conjunto de edades se presentaron estables en el período 2002-2019, mientras que la mortalidad presenta una tendencia decreciente en el período 1990-2020. En las mujeres menores de 45 años se encuentra un aumento en la incidencia, con mortalidad que decrece hasta el 2010, seguido de una estabilización de las tasas; en las mujeres de 45 a 69 años la incidencia se mantiene estable y la mortalidad decrece; en las mayores de 70 años, la incidencia decrece mientras la mortalidad se mantiene estable. Más del 70% de los casos se diagnostican en estadios I y II. Los tumores luminales (receptores hormonales positivos, HER2 negativos) son el subtipo más frecuente para todos los grupos, la proporción de tumores con estas características aumenta con la edad, mientras decrece la proporción de HER2 positivo y triple negativo. Conclusión: en las mujeres uruguayas el cáncer de mama presenta características diferenciales para las tres franjas de edades analizadas.

Abstract Metals can contaminate the environment and increasingly affect ecological systems and public health worldwide. Cu(II) and Pb(II) ions play a significant part in increasing the cancer rate, since their amounts are higher in cancerous patients than in healthy individuals. Electrochemical methods have been extensively used for analyzing biological, beverages and food samples to estimate Cu(II) and Pb(II). The present study has employed LSASV for Cu(II) and Pb(II) determination in female patients (suffering from breast-cancer) cancerous blood serum samples. Optimized conditions for analysis have required: Gc, with an eacc of -0.2 V and a tacc of 400 s, as WE; 0.1 M AB (pH 5.1) as SE, at a stirring rate of 9 rpm and SR of 100 mV/s-1; Ag/AgCl as RE; and a Pt wire as CE. Under the optimized conditions, the cost-effective procedure was successfully applied for Cu(II) and Pb(II) determination in cancerous human serum. LOD was in the range of ppb. The analysis indicated higher Cu(II) and Pb(II) levels in cancerous female patients than in the healthy ones. Therefore, a strictly controlled diet is recommended.

Introduction: Colorectal cancer is among the most common malignant neoplasms worldwide and the pre-malignant lesions that lead to its appearance are polyps in their various types. As a minimally invasive method, endoscopic resection emerges as the preferred method for focused lesions. Objective: To carry out a review verifying whether endoscopic therapy is safe and efficient in the treatment of lesions located in the rectum. Method: Narrative review collecting information published on virtual platforms (SciELO, Google Scholar, Pubmed and Scopus). Initially, a search was carried out for descriptors related to the topic, which were identified through DeCS/MeSH, namely: “colorectal cancer, adenoma, mucosectomy, dysplasia, polyp” with AND or OR search, considering the title and/or abstract. Afterwards, only those that were most similar were chosen, and the works were read in full. Results: 41 articles were evaluated. Conclusion: With the evolution of concepts and technological improvements, there is an increasing possibility of diagnosing non-polypoid or superficial lesions (superficially elevated, flat or depressed) and laterally spreading or laterally growing lesions or tumors (LST). ) that, by definition, have a diameter greater than 10 mm. Mucosectomy may be indicated for minimally invasive treatment or prevention in cases that have not yet advanced and can be cured endoscopically.

Introdução: O câncer colorretal está entre as neoplasias malignas mais comuns em todo mundo e as lesões pré-malignas que levam ao seu surgimento são os pólipos em seus variados tipos. Como forma minimamente invasiva a ressecção endoscópica desponta como método preferencial nas lesões focadas. Objetivo: Efetuar revisão verificando se a terapêutica endoscópica é segura e eficiente no tratamento de lesões localizadas no reto. Método: Revisão narrativa colhendo informações publicadas em plataformas virtuais (SciELO, Google Scholar, Pubmed e Scopus). Inicialmente foi realizada busca por descritores relacionados ao tema, os quais foram identificados por meio do DeCS/MeSH, a saber: “câncer colorretal, adenoma, mucosectomia, displasia, pólipo” e seus equivalentes em inglês “colorectal cancer, adenoma, mucosectomy, dysplasia, polyp” com busca AND ou OR, considerando o título e/ou resumo. Após, foram escolhidos somente os que tinham maior similitude, e realizada a leitura na íntegra dos trabalhos. Resultados: Foram avaliados 41 artigos. Conclusão: Com a evolução dos conceitos e com a melhora tecnológica, há possibilidade de diagnosticar cada vez maior lesões não-polipoides ou superficiais (superficialmente elevadas, planas ou deprimidas) e as lesões ou tumores de espraiamento ou crescimento lateral (LST, Laterally Spreading Tumor) que por definição apresentem diâmetro maior que 10 mm. A mucosectomia pode ser indicada para o tratamento minimanente invasivo ou prevenção nos casos ainda não avançados e que possam ser curados endoscopicamente.

Introduction: Non-melanoma skin neoplasms (basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) form the most common group of all types of neoplasms. Although cancer is not yet being classified as a channelopathy, it has been suggested that pumps and ionic channels contribute to its progression by affecting autophagy, which could become an important therapeutic target in this context. Objective: To evaluate the immunohistochemical expression of IP3R in both skin tumors. Method: Immunohistochemistry was performed on 60 slides of non-melanoma cancer using primary anti-IP3R antibodies, verifying their presence and quantifying Results: For the first time, IP3R immunolocalization was identified in non-melanoma skin neoplasms, being evident above 90% of neoplastic cells was observed in all slides studied, regardless of the histological pattern, invasion and other tumor characteristics. Unlike what was seen in the internal control of normal skin, in which there was immunolocalization of IP3R in basal cell, in tumors, immunohistochemical expression occurred throughout the entire body of the neoplasm. Conclusion: There was immunolocalization of IP3R in tumor cells in both BCC and SCC. It was not possible to establish a correlation between tumor characteristics and IP3R expression, as immunostaining was similar in all analyzed samples. Despite this, IP3R to be associated with the pathophysiology of non-melanoma skin cancer, but its expression does not seem to be associated with tumor aggressiveness.

Introdução: As neoplasias de pele não melanoma (carcinoma basocelular (CBC) e carcinoma espinocelular (CEC) formam o grupo mais comum de todos os tipos de neoplasias. Embora o câncer ainda não esteja sendo pautado como canalopatia, tem sido sugerido que bombas e canais iônicos contribuem para a sua progressão por afetar a autofagia. Proteínas iônicas, em especial as de canais de cálcio, como o receptor da fosfatidil inositol 3 (IP3R) participam de maneira ativa na autofagia por estarem envolvidas na etapa inicial de formação do autofagossomo, podendo se tornar em alvo terapêutico importante neste contexto. Objetivo: Avaliar a expressão imuno histoquímica do IP3R em ambos os tumores de pele. Método: Foi realizada imuno histoquímica em 60 lâminas de câncer não melanoma utilizando anticorpos primários anti-IP3R verificando a sua expressão. Resultados: Pela primeira vez foi identificada a imunolocalização do IP3R em câncer de pele não melanoma, sendo evidente em mais de 90% das células neoplásicas em todas as lâminas estudadas, independentemente do padrão histológico, invasão e demais características tumorais. Diferentemente do visualizado no controle interno de pele normal, no qual houve imunolocalização de IP3R em células basais, nos tumores, a expressão imuno histoquímica ocorreu em todo o corpo da neoplasia. Conclusão: Houve imunolocalização de IP3R em células tumorais tanto em CBC quanto em CEC. Não foi possível estabelecer correlação entre as características tumorais e a expressão de IP3R, pois a imunomarcação apresentou-se de forma similar em todas as amostras analisadas. Apesar disso, IP3R está associado à fisiopatologia do câncer de pele não melanoma, mas a sua expressão não parece estar associada à agressividade tumoral.